Zobrazeno 1 - 10
of 413
pro vyhledávání: '"multidrug-resistant TB"'
Modeling and analyzing the impact of limited medical resources and mutation on tuberculosis dynamics
Publikováno v:
Franklin Open, Vol 9, Iss , Pp 100186- (2024)
Tuberculosis (TB) remains a global health challenge despite the establishment of the End TB strategy which encouraged screening and treatment of latent patients. Existence of multiple disease strains and limited medical resources are some of the chal
Externí odkaz:
https://doaj.org/article/974936e68d364dbea4edea7c292764c7
Autor:
Yi Chu Liang, Zhiqi Sun, Chen Lu, Andréanne Lupien, Zhongliang Xu, Stefania Berton, Peng Xu, Marcel A. Behr, Weibo Yang, Jim Sun
Publikováno v:
Microbiology Spectrum, Vol 12, Iss 11 (2024)
ABSTRACT Mycobacterium tuberculosis (Mtb), the pathogen responsible for tuberculosis (TB), is the leading cause of bacterial disease-related death worldwide. Current antibiotic regimens for the treatment of TB remain dated and suffer from long treatm
Externí odkaz:
https://doaj.org/article/88ac151678dd48e9bf770881527a3769
Publikováno v:
Health Science Reports, Vol 7, Iss 10, Pp n/a-n/a (2024)
Abstract Background Tuberculosis (TB) remains a major public health concern in Pakistan, which is ranked fifth among high‐burden TB nations worldwide. The growing frequency of drug‐resistant TB strains, particularly multidrug‐resistant TB (MDR
Externí odkaz:
https://doaj.org/article/e8e76e29e6d347149f5bd4c0e3913a71
Publikováno v:
Jurnal Respirasi, Vol 10, Iss 2, Pp 137-142 (2024)
Introduction: The prolonged duration of tuberculosis (TB) treatment has led to an increase in non-compliance among TB patients undergoing anti-TB treatment, consequently leading to treatment failure and drug resistance, notably multidrug-resistant TB
Externí odkaz:
https://doaj.org/article/edca7fe7ab7942e990cbb916ac1c6646
Publikováno v:
South African Medical Journal, Vol 114, Iss 7 (2024)
Drug-resistant tuberculosis (TB) has poor outcomes unless resistance is detected early, ideally by commercially available molecular tests. We present a case of occult multidrug-resistant TB where both rifampicin and isoniazid resistance were missed b
Externí odkaz:
https://doaj.org/article/e8256ceec15e488a9774ceeb734b8b45
Publikováno v:
Egyptian Journal of Chest Disease and Tuberculosis, Vol 72, Iss 4, Pp 547-552 (2023)
Background Drug-resistant tuberculosis (DR-TB) is a global challenge. Owing to its high annual mortality and morbidity rates, as stated in the annual global TB reports provided by WHO, the prevalence of multidrug-resistant tuberculosis (MDR-TB) or ri
Externí odkaz:
https://doaj.org/article/d628d09f57b34100ae2e2abb78294ebb
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Viola Dreyer, Ayan Mandal, Prachi Dev, Matthias Merker, Ivan Barilar, Christian Utpatel, Kayzad Nilgiriwala, Camilla Rodrigues, Derrick W. Crook, the CRyPTIC Consortium, Jean-Philippe Rasigade, Thierry Wirth, Nerges Mistry, Stefan Niemann
Publikováno v:
Genome Medicine, Vol 14, Iss 1, Pp 1-16 (2022)
Abstract Background Multidrug-resistant (MDR) Mycobacterium tuberculosis complex (MTBC) strains are a serious health problem in India, also contributing to one-fourth of the global MDR tuberculosis (TB) burden. About 36% of the MDR MTBC strains are r
Externí odkaz:
https://doaj.org/article/a863ac7663954e59a0cf9e1e4f723e05
Autor:
Manoranjan Dash, Bibhu Prasad Behera
Publikováno v:
Journal of Family Medicine and Primary Care, Vol 11, Iss 4, Pp 1275-1281 (2022)
Introduction: India accounts for one-fourth of the global TB burden. The load of drug-resistant TB is of foremost attention and concern at international, regional, and national levels. As per estimates of TB burden in India in 2018, the MDR/RR-TB inc
Externí odkaz:
https://doaj.org/article/653dd3793e9144228bca6be00da4d0e3